Correlation Between Genmab AS and Wealth Inv
Specify exactly 2 symbols:
By analyzing existing cross correlation between Genmab AS and Wealth Inv Allspring, you can compare the effects of market volatilities on Genmab AS and Wealth Inv and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Wealth Inv. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Wealth Inv.
Diversification Opportunities for Genmab AS and Wealth Inv
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Genmab and Wealth is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Wealth Inv Allspring in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wealth Inv Allspring and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Wealth Inv. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wealth Inv Allspring has no effect on the direction of Genmab AS i.e., Genmab AS and Wealth Inv go up and down completely randomly.
Pair Corralation between Genmab AS and Wealth Inv
Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Wealth Inv. In addition to that, Genmab AS is 1.31 times more volatile than Wealth Inv Allspring. It trades about -0.03 of its total potential returns per unit of risk. Wealth Inv Allspring is currently generating about 0.26 per unit of volatility. If you would invest 17,350 in Wealth Inv Allspring on September 2, 2024 and sell it today you would earn a total of 1,255 from holding Wealth Inv Allspring or generate 7.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 86.36% |
| Values | Daily Returns |
Genmab AS vs. Wealth Inv Allspring
Performance |
| Timeline |
| Genmab AS |
| Wealth Inv Allspring |
Genmab AS and Wealth Inv Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genmab AS and Wealth Inv
The main advantage of trading using opposite Genmab AS and Wealth Inv positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Wealth Inv can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wealth Inv will offset losses from the drop in Wealth Inv's long position.| Genmab AS vs. Ambu AS | Genmab AS vs. DSV Panalpina AS | Genmab AS vs. Bavarian Nordic | Genmab AS vs. GN Store Nord |
| Wealth Inv vs. Nordfyns Bank AS | Wealth Inv vs. Carnegie Wealth Management | Wealth Inv vs. BankInvest Value Globale | Wealth Inv vs. Spar Nord Bank |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |